Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Open accessThe DOI matches its Crossref record; 273 of the 276 references it cites were found in a registry or an index.
Abstract
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. LATE-NC is a common TDP-43 proteinopathy, associated with an amnestic dementia syndrome that mimicked Alzheimer's-type dementia in retrospective autopsy studies. LATE is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on its epidemiology (LATE generally affects older subjects), and relatively restricted neuroanatomical distribution of TDP-43 proteinopathy. In community-based autopsy cohorts, ∼25% of brains had sufficient burden of LATE-NC to be associated with discernible cognitive impairment. Many subjects with LATE-NC have comorbid brain pathologies, often including amyloid-β plaques and tauopathy. Given that the 'oldest-old' are at greatest risk for LATE-NC, and subjects of advanced age constitute a rapidly growing demographic group in many countries, LATE has an expanding but under-recognized impact on public health. For these reasons, a working group was convened to develop diagnostic criteria for LATE, aiming both to stimulate research and to promote awareness of this pathway to dementia. We report consensus-based recommendations including guidelines for diagnosis and staging of LATE-NC. For routine autopsy workup of LATE-NC, an anatomically-based preliminary staging scheme is proposed with TDP-43 immunohistochemistry on tissue from three brain areas, reflecting a hierarchical pattern of brain involvement: amygdala, hippocampus, and middle frontal gyrus. LATE-NC appears to affect the medial temporal lobe structures preferentially, but other areas also are impacted. Neuroimaging studies demonstrated that subjects with LATE-NC also had atrophy in the medial temporal lobes, frontal cortex, and other brain regions. Genetic studies have thus far indicated five genes with risk alleles for LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE. The discovery of these genetic risk variants indicate that LATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's disease, but also suggests disease-specific underlying mechanisms. Large gaps remain in our understanding of LATE. For advances in prevention, diagnosis, and treatment, there is an urgent need for research focused on LATE, including in vitro and animal models. An obstacle to clinical progress is lack of diagnostic tools, such as biofluid or neuroimaging biomarkers, for ante-mortem detection of LATE. Development of a disease biomarker would augment observational studies seeking to further define the risk factors, natural history, and clinical features of LATE, as well as eventual subject recruitment for targeted therapies in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Statistical analyses on data related to LATE from the Rush University community-based autopsy cohort depicting the results of pathway analyses. Data were analysed from research volunteers (total n = 1309) in two clinical‐pathological studies of ageing from Rush University as described previously (Power et al., 2018). In this sample, the mean age of death was 89.7 years [standard deviation (SD) 6.5 years, range 65–108 years]. These analyses incorporated age, density of amyloid-β neuritic amyloid plaques (to factor in ADNC), TDP-43 proteinopathy, hippocampal sclerosis pathology, and the endpoint of Alzheimer’s-type clinical dementia. The components of the pathway analyses most strongly associated with LATE-NC are shown in red. The numbers are path coefficients with standard error in parentheses (shown in purple). These numbers help to quantify the effects of individual pathways. For instance, the data are compatible with there being two pathways from TDP-43 proteinopathy to dementia, one direct pathway (TDP-43 proteinopathy→dementia) and the other indirect pathway that includes hippocampal sclerosis pathology (TDP-43 proteinopathy→hippocampal sclerosis→dementia): in the statistical model, the TDP-43 proteinopathy is independently associated with both hippocampal sclerosis pathology and clinical dementia status. Further, the data indicate that a subset of TDP-43 proteinopathy is ‘downstream’ of ADNC-type neuritic amyloid plaque pathology. In a practical sense, this means that brains with more neuritic amyloid plaques are more likely to have TDP-43 proteinopathy, with all other known factors being the same. Aβ = amyloid-β.](https://figures.cochat.ai/paper-figures/9bc83b3adf7f42d5a250b59d9652e7a1/limbic-predominant-age-related-tdp-43-encephalopathy-late-consensus-working-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A consensus group, for example, has described hippocampal sclerosis associated with TDP-43 proteinopathy, as limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia, usually found in people older than 80 years, progressing more slowly than Alzheimer's disease, detectable at post-mortem, often mimicking or comorbid with Alzheimer's disease.3”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“50–60% of Alzheimer’s-type dementia (dementia defined clinically as Alzheimer’s disease) is estimated to be attributable to these copathologies.40,42–45”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE is a recently described entity which affects older people and presents with an amnestic picture resembling Alzheimer's disease 178 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [178]
The cited source says what the claim attributes to it.
In the citing paper
“Limbic-predominant age-related TDP43 encephalopathy (LATE), defined approximately 3 years ago, is a condition in which typical TDP43 protein inclusions are present with or without coexisting hippocampal sclerosis.29”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“The predominant neuropathological change in LATE is TDP-43 proteinopathy, which is associated with a clinical presentation of amnestic dementia that can mimic Alzheimer's dementia.”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationBlessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“LATE-NC is mostly seen in the oldest-old, whereas in early clinical-pathological correlation studies of dementia (Roth et al., 1966; Blessed et al., 1968), the research subjects had died in their early 70s.”
BackgroundAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · cited 1×
“This stratification will enable enrichment for subjects on the ADNC continuum (Sevigny et al., 2016) while excluding subjects likely to have high risk for LATE-NC (Botha et al., 2018).”
BackgroundMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationStages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 1×
“seen at autopsy with every year of advanced old age (Braak et al., 2011; Nelson et al., 2011a, 2013; Brenowitz et al., 2014; Neltner et al., 2016).”
BackgroundPorta, M. (2026) · doi:10.1093/acref/9780197663639.001.0001 · Cited by 2,175
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citation
Research works printed but not linked: 3
- Kuslansky G, Verghese J, Dickson D, Katz M, Busche H, Lipton RB Hippocampal sclerosis: cognitive consequences and contribution to dementia. Neurology 2004; 62: A128– 9.
- Porta M. Dictionary of Epidemiology. 6th edn. New York: Oxford University Press; 2014.
- Thom M, Sisodiya S Epilepsy. In: Love S, Perry A, Ironside JW, Budka H, editors. Greenfield’s Neuropathology. New York: CRC Press; 2015 p. 683– 739.
Cited by
Items 301–400 of 1,004
CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD
Santangelo, R., Masserini, F., Agosta, F., Sala, A., Caminiti, S. P., Cecchetti, G., Caso, F., Martinelli, V., Pinto, P., Passerini, G., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04853-4 · Cited by 40
Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer’s disease
Latimer, C. S., & Liachko, N. F. (2021) · GeroScience · doi:10.1007/s11357-021-00407-0 · Cited by 39
Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging
Oveisgharan, S., Yu, L., Poole, V. N., Evia, A. M., Barnes, L. L., Schneider, J. A., Arfanakis, K., Bennett, D. A., & Buchman, A. S. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3996 · Cited by 40
Self-citationCerebral glucose metabolism in Alzheimer's disease
Salmon, É., Collette, F., & Bastin, C. (2024) · Cortex · doi:10.1016/j.cortex.2024.07.004 · Cited by 39
Dang, M., Kang, J., Lim, L., Li, Y., Wang, L., & Song, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.088 · Cited by 39
Bourassa, P., Tremblay, C., Schneider, J. A., Bennett, D. A., & Calon, F. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12599 · Cited by 39
Self-citationCo-pathologies in Alzheimer’s disease: just multiple pathologies or partners in crime?
Tomé, S. O., & Thal, D. R. (2021) · Brain · doi:10.1093/brain/awab027 · Cited by 39
Nelson, P. T. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab050 · Cited by 39
Self-citationAfroz, T., Chevalier, E., Audrain, M., Dumayne, C., Ziehm, T., Moser, R., Egesipe, A.-L., Mottier, L., Ratnam, M., Neumann, M., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106050 · Cited by 39
Self-citationHokkanen, S. R. K., Kero, M., Kaivola, K., Hunter, S., Keage, H. A. D., Kiviharju, A., Raunio, A., Tienari, P. J., Paetau, A. E., Matthews, F. E., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12773 · Cited by 39
Self-citationHarrison, W. T., Lusk, J. B., Liu, B., Ervin, J. F., Johnson, K. G., Green, C. L., & Wang, S. J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02360-w · Cited by 39
Maldonado‐Díaz, C., Hiya, S., Yokoda, R. T., Farrell, K. W., Marx, G. A., Kauffman, J., Daoud, E. V., Gonzales, M. M., Parker, A. S., Canbeldek, L., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02716-y · Cited by 38
Verde, E. M., Secco, V., Ghezzi, A., Mandrioli, J., & Carra, S. (2025) · Cells · doi:10.3390/cells14100680 · Cited by 38
Coutinho, A. M., Busatto, G. F., Porto, F. H. D. G., Faria, D. D. P., Ono, C. R., Garcez, A. T., Squarzoni, P., Duran, F., de Oliveira, M. O., Trés, E. S., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04714-0 · Cited by 38
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP
Feneberg, E., Charles, P. D., Finelli, M. J., Scott, C., Kessler, B. M., Fischer, R., Ansorge, O., Gray, E., Talbot, K., & Turner, M. R. (2021) · Brain Pathology · doi:10.1111/bpa.12923 · Cited by 38
Multiple Subtypes of Alzheimer’s Disease Base on Brain Atrophy Pattern
Zhang, B., Lin, L., Wu, S., & Al-Masqari, Z. (2021) · Brain Sciences · doi:10.3390/brainsci11020278 · Cited by 38
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
Wisse, L. E. M., de Florès, R., Xie, L., Das, S. R., McMillan, C. T., Trojanowski, J. Q., Grossman, M., Lee, E. B., Irwin, D. J., Yushkevich, P. A., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00835-2 · Cited by 38
Self-citationMotor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Riku, Y., Iwasaki, Y., Ishigaki, S., Akagi, A., Hasegawa, M., Nishioka, K., Li, Y., Riku, M., Ikeuchi, T., Fujioka, Y., et al. (2022) · Brain · doi:10.1093/brain/awac091 · Cited by 38
Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology
Bayram, E., Coughlin, D. G., & Litvan, I. (2022) · Movement Disorders · doi:10.1002/mds.29044 · Cited by 38
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., & Ishigaki, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415755 · Cited by 38
Sordo, L., Qian, T., Bukhari, S. A., Nguyen, K. M., Woodworth, D. C., Head, E., Kawas, C. H., Corrada, M. M., Montine, T. J., & Sajjadi, S. A. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02606-9 · Cited by 38
Self-citationHuang, Z., Merrihew, G. E., Larson, E. B., Park, J., Plubell, D., Fox, E. J., Montine, K. S., Latimer, C. S., Dirk Keene, C., Zou, J. Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38376-x · Cited by 37
Self-citationCryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research
Todd, T. W., Islam, N. N., Cook, C. N., Caulfield, T. R., & Petrucelli, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.012 · Cited by 37
Development of [18F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology
Vokali, E., Chevalier, E., Dreyfus, N., Charmey, D., Melly, T., Kocher, J., Ratnam, M., Serra, A. M., Jaquier, T., Delgado, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64540-6 · Cited by 36
Self-citationRizuan, A., Shenoy, J., Mohanty, P., dos Passos, P. M., Ortiz, J. F. M., Bai, L., Viswanathan, R., Zaborowksy, J., Wang, S., Johnson, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65546-w · Cited by 37
Rosenberg, A., Solomon, A., Jelić, V., Hagman, G., Bogdanović, N., & Kivipelto, M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0557-1 · Cited by 37
Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents
Nag, S., Barnes, L. L., Yu, L., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2020) · Neurology · doi:10.1212/wnl.0000000000010602 · Cited by 38
Self-citationNovel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Wilson, H., Politis, M., Rabiner, E. A., & Middleton, L. T. (2020) · Cells · doi:10.3390/cells9122581 · Cited by 37
Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
Lucini, C. B., & Braun, R. J. (2021) · Biomedicines · doi:10.3390/biomedicines9040376 · Cited by 37
Gessi, S., Poloni, T. E., Negro, G., Varani, K., Pasquini, S., Vincenzi, F., Borea, P. A., & Merighi, S. (2021) · Cells · doi:10.3390/cells10092344 · Cited by 37
Vitamin B12 Reduces TDP-43 Toxicity by Alleviating Oxidative Stress and Mitochondrial Dysfunction
Jeon, Y., Kwon, Y., Lee, S., Kim, S., Jo, M., Lee, S., Kim, S. R., Kim, K., & Kim, H. (2021) · Antioxidants · doi:10.3390/antiox11010082 · Cited by 37
Versluys, L., Pereira, P. E., Schuermans, N., Paepe, B. D., Bleecker, J. D., Bogaert, E., & Dermaut, B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.815765 · Cited by 37
Laczó, M., Martinkovič, L., Lerch, O., Wiener, J. M., Kalinová, J., Matušková, V., Nedelská, Z., Vyhnálek, M., Hort, J., & Laczó, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.886778 · Cited by 37
Human amygdala involvement in Alzheimer's disease revealed by stereological and dia‐PASEF analysis
Gonzalez‐Rodriguez, M., Villar‐Conde, S., Astillero‐Lopez, V., Villanueva‐Anguita, P., Ubeda‐Banon, I., Flores‐Cuadrado, A., Martinez‐Marcos, A., & Saiz‐Sanchez, D. (2023) · Brain Pathology · doi:10.1111/bpa.13180 · Cited by 36
“Recently, limbic-predominant age-related TDP-43 encephalopathy (LATE) has been described as new disease entity characterized by TDP-43 proteinopathy and Alzheimer’s type dementia, being the amygdala involved from early stages [10, 11].”
BackgroundPredictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
Pozzi, F. E., Conti, E., Appollonio, I., Ferrarese, C., & Tremolizzo, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.998224 · Cited by 36
Pottier, C. P., Küçükali, F., Baker, M. C., Batzler, A. J., Jenkins, G. D., van Blitterswijk, M., Vicente, C. T., Coster, W. D., Wynants, S., de Walle, P. V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59216-0 · Cited by 36
Self-citationBouwman, M. M. A., Frigerio, I., Lin, C., Reijner, N., van de Berg, W. D. J., & Jonkman, L. E. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01768-w · Cited by 37
Dementia-related psychosis and the potential role for pimavanserin
Cummings, J. L., Devanand, D. P., & Stahl, S. M. (2020) · CNS Spectrums · doi:10.1017/s1092852920001765 · Cited by 37
Louis, E. D., Hernandez, D. I., Hernandez, N. C., Flowers, X. E., Kuo, S., Vonsattel, J. P., & Faust, P. L. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac068 · Cited by 37
Interpretable deep learning of myelin histopathology in age-related cognitive impairment
McKenzie, A. T., Marx, G. A., Koenigsberg, D., Sawyer, M., Iida, M. A., Walker, J. M., Richardson, T. E., Campanella, G. S. V., Attems, J., McKee, A. C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01425-5 · Cited by 36
Self-citationThe correlation between neuropathology levels and cognitive performance in centenarians
Zhang, M., Ganz, A. B., Rohde, S. K., Lorenz, L. M. C., Rozemüller, A. J. M., van Vliet, K., Graat, M., Sikkes, S. A. M., Reinders, M. J. T., Scheltens, P., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13087 · Cited by 36
Saltiel, N. A., Tripodis, Y., Menzin, T. J., Olaniyan, A., Baucom, Z. H., Yhang, E., Palmisano, J. N., Martin, B. M., Uretsky, M., Nair, E. S., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26823 · Cited by 36
Self-citationIndividuals with Alzheimer's disease and low tau burden: Characteristics and implications
Landau, S. M., Lee, J., Murphy, A., Ward, T. J., Harrison, T. M., Baker, S. L., DeCarli, C. S., Harvey, D. J., Tosun, D., Weiner, M. W., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13609 · Cited by 37
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
Khalil, B., Linsenmeier, M., Smith, C. L., Shorter, J., & Rossoll, W. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00698-1 · Cited by 36
Khan, A. F., & Iturria‐Medina, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03073-w · Cited by 35
Shiells, H., Schelter, B. O., Bentham, P., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanović, V., Staff, R. T., Murray, A. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191173 · Cited by 35
Mock, C., Teylan, M., Beecham, G. W., Besser, L. M., Cairns, N. J., Crary, J. F., Katsumata, Y., Nelson, P. T., & Kukull, W. A. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000380 · Cited by 35
Self-citationStroobants, S., D’Hooge, R., & Damme, M. (2021) · Brain Pathology · doi:10.1111/bpa.12903 · Cited by 31
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Wegiel, J., Ma, S. Y., Zhong, N., Wierzba‐Bobrowicz, T., de Leon, M., Lai, F., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01300-9 · Cited by 35
Association of glial tau pathology and LATE-NC in the ageing brain
Forrest, S. L., Wagner, S., Kim, A., & Kovács, G. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.010 · Cited by 35
Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
Winston, C. N., Sukreet, S., Lynch, H. M., Lee, V. M. ‐., Wilcock, D. M., Nelson, P. T., & Rissman, R. A. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12365 · Cited by 35
Self-citationManca, M., Standke, H. G., Browne, D. F., Huntley, M. L., Thomas, O. R., Orru, C. D., Hughson, A. G., Kim, Y., Zhang, J., Tatsuoka, C. M., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02574-0 · Cited by 35
Hanseeuw, B. J., Jacobs, H. I. L., Schultz, A. P., Buckley, R. F., Farrell, M. E., Guehl, N. J., Becker, J. A., Properzi, M. J., Sanchez, J. S., Quiroz, Y. T., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207962 · Cited by 35
Self-citationCryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Chung, M., Carter, E. K., Veire, A. M., Dammer, E. B., Chang, J., Duong, D. M., Raj, N., Bassell, G. J., Glass, J. D., Gendron, T. F., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02671-0 · Cited by 35
Self-citationChallenges in a Biological Definition of Alzheimer Disease
Hazan, J., Liu, K. Y., Costello, H., Isaacs, J. D., Thambisetty, M., & Howard, R. J. (2024) · Neurology · doi:10.1212/wnl.0000000000209884 · Cited by 34
Aikio, M., Odeh, H. M., Wobst, H. J., Lee, B. L., Chan, Ú., Mauna, J. C., Mack, K. L., Class, B., Ollerhead, T. A., Ford, A. F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115205 · Cited by 34
SUMO2/3 conjugation of TDP-43 protects against aggregation
Verde, E. M., Antoniani, F., Mediani, L., Secco, V., Crotti, S., Ferrara, M. C., Vinet, J., Sergeeva, A. V., Yan, X., Hoege, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq2475 · Cited by 34
Amyloid-Beta Pathology and Cognitive Performance in Centenarians
Rohde, S. K., Luimes, M. C., Lorenz, L. M. C., Fierro‐Hernández, P., Rozemüller, A. J. M., Hulsman, M., Zhang, M., Graat, M., van der Hoorn, M. E., Daatselaar, D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1734 · Cited by 34
Katsumata, Y., Fardo, D. W., Bachstetter, A. D., Artiushin, S., Wang, W., Wei, A. L., Brzezinski, L. J., Nelson, B. G., Huang, Q., Abner, E. L., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz116 · Cited by 34
Self-citationThe role of synaptic biomarkers in the spectrum of neurodegenerative diseases
Mazzucchi, S., Palermo, G., Campese, N., Galgani, A., Vecchia, A. D., Vergallo, A., Siciliano, G., Ceravolo, R., Hampel, H. J., & Baldacci, F. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1831388 · Cited by 34
Tau pathology associates with in vivo cortical thinning in Lewy body disorders
Spotorno, N., Coughlin, D. G., Olm, C. A., Wolk, D. A., Vaishnavi, S., Shaw, L. M. J., Dahodwala, N. A., Morley, J. F., Duda, J. E., Deik, A., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51183 · Cited by 34
Self-citationLiu, K. Y., Reeves, S., McAleese, K. E., Attems, J., Francis, P. T., Thomas, A. J., & Howard, R. J. (2020) · Brain · doi:10.1093/brain/awaa315 · Cited by 34
Self-citationClinical relevance of brain atrophy subtypes categorization in memory clinics
Planche, V., Bouteloup, V., Mangin, J., Dubois, B., Delrieu, J., Pasquier, F., Blanc, F., Paquet, C., Hanon, O., Gabelle, A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12231 · Cited by 34
Park, S.-Y., Setiawan, V. W., Crimmins, E. M., White, L. R., Wu, A. H., Cheng, I., Darst, B. F., Haiman, C. A., Wilkens, L. R., Le Marchand, L., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208116 · Cited by 33
Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study
Mikhailenko, E., Colangelo, K., Tuimala, J., Kero, M., Savola, S. E., Raunio, A., Kok, E., Tanskanen, M., Mäkelä, M., Puttonen, H. A. J., et al. (2024) · Brain · doi:10.1093/brain/awae212 · Cited by 33
Sun, P., He, Z., Li, A., Yang, J., Zhu, Y., Cai, Y. Q., Ma, T., Ma, S., Guo, T., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14176 · Cited by 33
Schoor, E. V., Koper, M. J., Ospitalieri, S., Dedeene, L., Tomé, S. O., Vandenberghe, R. R., Brenner, D., Otto, M., Weishaupt, J. H., Ludolph, A. C., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12668 · Cited by 34
11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous
Abrahamson, E. E., Kofler, J., Becker, C. R., Price, J. C., Newell, K. L., Ghetti, B. F., Murrell, J. R., McLean, C., López, O. L., Mathis, C. A., et al. (2021) · Brain · doi:10.1093/brain/awab434 · Cited by 33
Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
Mohanty, R., Ferreira, D., Frerich, S., Muehlboeck, J., Grothe, M. J., Westman, E., & Initiative, A. D. N. (2022) · Neurology · doi:10.1212/wnl.0000000000200573 · Cited by 33
Inglese, M., Patel, N., Linton‐Reid, K., Loreto, F., Win, Z., Perry, R. J., Carswell, C. J., Grech‐Sollars, M., Crum, W. R., Lu, H., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00133-4 · Cited by 33
Self-citationModulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10
Liu, T., Woo, J. A., Bukhari, M. Z., Wang, X., Yan, Y., Cazzaro, S., Ermekbaeva, A., Sista, A., Kotsiviras, P., LePochat, P., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01386-9 · Cited by 33
Duong, M. T., & Wolk, D. A. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01232-4 · Cited by 33
Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia
Kara, B., Gordon, M. N., Gifani, M., Dorrance, A. M., & Counts, S. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2022.07.006 · Cited by 33
The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease
Bendtsen, K. M., & Hall, V. J. (2023) · Cells · doi:10.3390/cells12030420 · Cited by 33
Highly Charged Proteins and Their Repulsive Interactions Antagonize Biomolecular Condensation
Tan, C., Niitsu, A., & Sugita, Y. (2023) · JACS Au · doi:10.1021/jacsau.2c00646 · Cited by 33
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
Necarsulmer, J., Simon, J. M., Evangelista, B., Chen, Y., Tian, X., Nafees, S., Gonzalez, A. M., Jiang, H., Wang, P., Ajit, D., et al. (2023) · eLife · doi:10.7554/elife.85921 · Cited by 33
Kumar, S., Phaneuf, D., & Julien, J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00952-0 · Cited by 33
Frailty and neuropathology in relation to dementia status: the Cambridge City over-75s Cohort study
Wallace, L. M. K., Hunter, S., Theou, O., Fleming, J., Rockwood, K. J., & Brayne, C. (2021) · International Psychogeriatrics · doi:10.1017/s1041610220003932 · Cited by 33
Self-citationÁlvarez-Sánchez, L., Peña-Bautista, C., Ferré-González, L., Balaguer, A., Baquero, M., Casanova-Estruch, B., & Cháfer-Pericás, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021226 · Cited by 32
Tosun, D., Yardibi, O., Benzinger, T. L. S., Kukull, W. A., Masters, C. L., Perrin, R. J., Weiner, M. W., Simen, A. A., Schwarz, A. J., & Initiative, A. D. N. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13447 · Cited by 32
Self-citationDoes amnesia specifically predict Alzheimer’s pathology? A neuropathological study
Bertoux, M., Cassagnaud, P., Lebouvier, T., Lebert, F., Sarazin, M., Ber, I. L., Dubois, B., Auriacombe, S., Hannequin, D., Wallon, D., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.011 · Cited by 32
Stage, E., Svaldi, D. O., Phillips, M. L., Canela, V. H., Duran, T., Goukasian, N., Risacher, S. L., Saykin, A. J., Apostolova, L. G., & Initiative, A. D. N. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00647-w · Cited by 32
The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates
Creekmore, B. C., Chang, Y., & Lee, E. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab039 · Cited by 32
Smirnov, D. S., Salmon, D. P., Galasko, D. R., Goodwill, V., Hansen, L. A., Zhao, Y., Edland, S. D., Léger, G. C., Peavy, G. M., Jacobs, D. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013107 · Cited by 32
Self-citationTMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
Feng, T., Luan, L., Katz, I. I., Ullah, M., Deerlin, V. M. V., Trojanowski, J. Q., Lee, E. B., & Hu, F. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01334-7 · Cited by 32
Self-citationJury-Garfe, N., Redding-Ochoa, J., You, Y., Martínez, P., Karahan, H., Chimal-Juárez, E., Johnson, T. S., Zhang, J., Resnick, S., Kim, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02775-1 · Cited by 31
“Assessment of TDP-43 changes in AD cases was conducted as recommended by Nelson et al. 2019 and 2023 [65, 66].”
MethodRNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo
Scherer, N. M., Maurel, C., Graus, M. S., McAlary, L., Richter, G., Radford, R. A. W., Hogan, A. L., Don, E. K., Lee, A., Yerbury, J. J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae112 · Cited by 31
Dysautonomia in Alzheimer's Disease
Tulbă, D., Cozma, L., Popescu, B. O., & Davidescu, E. I. (2020) · Medicina · doi:10.3390/medicina56070337 · Cited by 31
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 31
Borrego‐Écija, S., Turón‐Sans, J., Ximelis, T., Aldecoa, I., Molina‐Porcel, L., Povedano, M., Rubio, M. Á., Gámez, J., Cano, A., Paré, M., et al. (2021) · Brain Pathology · doi:10.1111/bpa.12942 · Cited by 31
Arezoumandan, S., Xie, S. X., Cousins, K. A. Q., Mechanic-Hamilton, D. J., Peterson, C. S., Huang, C. Y., Ohm, D. T., Ittyerah, R., McMillan, C. T., Wolk, D. A., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02472-x · Cited by 31
Self-citationPrevalence of chronic traumatic encephalopathy in the Sydney Brain Bank
McCann, H., Bahar, A. Y., Burkhardt, K., Gardner, A. J., Halliday, G. M., Iverson, G. L., & Shepherd, C. E. (2022) · Brain Communications · doi:10.1093/braincomms/fcac189 · Cited by 32
Self-citationTREM2 risk variants are associated with atypical Alzheimer’s disease
Kim, B., Suh, E. R., Nguyen, A. T., Prokop, S., Mikytuck, B., Olatunji, O. A., Robinson, J. L., Grossman, M., Phillips, J. S., Irwin, D. J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02495-4 · Cited by 31
Self-citationBeagle, A. J., Zahir, A. T., Borzello, M., Kayser, A. S., Hsu, M., Miller, B. L., Kramer, J. H., & Chiong, W. (2019) · Cortex · doi:10.1016/j.cortex.2019.10.009 · Cited by 32
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296 · Cited by 31
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Koga, S., Zhou, X., Murakami, A., Fernandez De Castro, C., Baker, M. C., Rademakers, R., & Dickson, D. W. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12778 · Cited by 30
Self-citationAmygdala atrophies in specific subnuclei in preclinical Alzheimer's disease
Salman, Y., Gérard, T., Huyghe, L., Colmant, L., Quenon, L., Malotaux, V., Ivanoiu, A., Lhommel, R., Dricot, L., Hanseeuw, B. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14235 · Cited by 30
Jiang, L., Zhang, X.-L., & Hu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212380 · Cited by 30
Wang, D., Honnorat, N., Toledo, J. B., Li, K., Charisis, S., Rashid, T., Nirmala, A. B., Brandigampala, S. R., Mojtabai, M., Seshadri, S. S., et al. (2024) · Brain · doi:10.1093/brain/awae388 · Cited by 30
Borland, E., Stomrud, E., van Westen, D., Hansson, O., & Palmqvist, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00592-8 · Cited by 31
Metadata
- Authors
- Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., Coyle-Gilchrist, I. T. S., Chui, H. C., Fardo, D. W., Flanagan, M. E., Halliday, G., Hokkanen, S. R. K., Hunter, S., Jicha, G. A., Katsumata, Y., Kawas, C. H., Keene, C. D., Kovacs, G. G., Kukull, W. A., Levey, A. I., Makkinejad, N., Montine, T. J., Murayama, S., Murray, M. E., Nag, S., Rissman, R. A., Seeley, W. W., Sperling, R. A., White III, C. L., Yu, L., & Schneider, J. A.
- Affiliations
- University of Kentucky (US)
- Mayo Clinic in Florida (US)
- University of Pennsylvania (US)
- Mayo Clinic (US)
- Rush University Medical Center (US)
- Uppsala University (SE)
- Newcastle University (GB)
- University of Cambridge (GB)
- University of Southern California (US)
- University of Minnesota (US)
- The University of Sydney (AU)
- University of California, Irvine (US)
- University of Washington (US)
- Institute of Neurology Medical University of Vienna, Vienna, Austria
- Emory University (US)
- Illinois Institute of Technology (US)
- Stanford University (US)
- Tokyo Metropolitan Institute of Gerontology (JP)
- University of California San Diego (US)
- University of California, San Francisco (US)
- Harvard University (US)
- University of Texas Southwestern Medical Center, Dallas, TX, USA
- Corresponding author
- Nelson, Peter T
- ORCID
- Nelson, Peter T
- Dickson, Dennis W
- Trojanowski, John Q
- Jack, Clifford R
- Boyle, Patricia A
- Arfanakis, Konstantinos
- Rademakers, Rosa
- Alafuzoff, Irina
- Attems, Johannes
- Brayne, Carol
- Coyle-Gilchrist, Ian T S
- Chui, Helena C
- Fardo, David W
- Flanagan, Margaret E
- Halliday, Glenda
- Hokkanen, Suvi R K
- Hunter, Sally
- Jicha, Gregory A
- Katsumata, Yuriko
- Kawas, Claudia H
- Keene, C Dirk
- Kukull, Walter A
- Levey, Allan I
- Makkinejad, Nazanin
- Montine, Thomas J
- Murayama, Shigeo
- Murray, Melissa E
- Nag, Sukriti
- Rissman, Robert A
- Seeley, William W
- Sperling, Reisa A
- Yu, Lei
- Schneider, Julie A
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-30
- Volume
- 142
- Issue
- 6
- Pages
- 1503-1527
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6536849
- OpenAlex
- W2943828894
- Cited by
- 1,547
- References
- 276
- Citations by year
- 2026: 206 · 2025: 240 · 2024: 211 · 2023: 214 · 2022: 213 · 2021: 193 · 2020: 198 · 2019: 66
- FWCI
- 113.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Apollo
- Funders
- NIA
- NACC
- NIH (U01 AG016976)
- National Health and Medical Research Council
- NHMRC (1132524, 1095127, 1037746)
- Senior Principal Research Fellowship (1079679)
- National Institutes of Health (P01 AG003949, R01 AG037491, P50 AG016574, R01 AG054449, P30 AG028303, P30 AG012300, P30 AG049638, P30 AG010124, P30 AG010161, P50 AG047366, P50 AG025688, P50 AG005131, R37 AG011378, R01 AG041851, R01 AG042210, R01 AG017917, R01 AG034374, UF1 AG053983, UF1 AG057707)
- NIHR (534906, NF-SI-0616–10090)
- National Institute for Health Research
- NHS
- Department of Health and Social Care
- Addenbrooke’s Charitable Trust
- Paul G. Allen Family Foundation and Alzheimer’s Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- limbic-predominant age-related TDP-43 encephalopathy, TDP-43 proteinopathy, hippocampal sclerosis, diagnostic criteria, neuropathological staging, amygdala, medial temporal lobe atrophy, genetic risk variants, gene regulatory networks, TMEM106B, ABCC9, apolipoprotein E, Alzheimer's disease, frontotemporal lobar degeneration
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Diseases, Female, Humans, Male, Middle Aged, Retrospective Studies, Frontotemporal Lobar Degeneration, TDP-43 Proteinopathies, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.